"In summary, our results indicate that HemoHIM inhibited a reduction in the lung inflammatory response on CS and LPS induced lung inflammation via the Erk pathway. Therefore, we suggest that HemoHIM has the potential to treat pulmonary inflammatory disease such as COPD."*
Source: HemoHIM, a herbal preparation, alleviates airway inflammation caused by cigarette smoke and lipopolysaccharide (Retrieved 2021/7/7).
*The verbiage inside the quotation marks was retrieved from the source mentioned above, and does not represent the views or opinions of HemoHIMreview.com.
0 Comments